The compound reaches Cmax (maximum plasma concentration) within 1530 minutes of subcutaneous injection, binds selectively to ghrelin receptors (specifically the growth hormone secretagogue receptor type 1a, GHS-R1a) on pituitary somatotrophs, and triggers acute growth hormone secretion that peaks 3045 minutes post-injection
Research Use Limitation Used solely for laboratory and in vitro research Not approved for human consumption Not approved for veterinary use Not intended for diagnostic purposes Not intended for therapeutic applications Not permitted for clinical administration For research use only Independently analysed by Liquilabs s.r.o
Over the long term, these peptides can help maintain somewhat more stable growth hormone levels, which can protect bone density and reduce the risk for things like osteoporosis
This mechanism complements the bodys natural GH rhythm, making ipamorelin one of the cleanest and most predictable growth hormone peptides available
Going from 100 mcg to 300 mcg does not triple GH output
This is not a problem with the protocol